|
Synonyms: STK-001 | STK001
Compound class:
Nucleic acid
Comment: Zorevunersen (STK-001) is an antisense oligonucleotide (ASO) that targets sodium voltage-gated channel alpha subunit 1 (SCN1A) pre-mRNA transcript, to promote an increase in Nav1.1 channel protein in neurons. It is intended as a disease-modifying treatment for Dravet syndrome, where SCN1A haploinsufficiency disrupts Nav1.1 protein production.
Full sequence is: all-P-ambo-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'→5')-2'-O-(2-methoxyethyl)-5-methylcytidine |
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | Antisense oligonucleotide (ASO) |
| Target | SCN1A pre-mRNA |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11795 | zorevunersen |
Synonyms ![]() |
| STK-001 | STK001 |
Database Links ![]() |
|
| CAS Registry No. | 2415330-04-8 (source: WHO INN record) |
| DrugBank Ligand | DB16912 |
| Search PubMed clinical trials | zorevunersen |
| Search PubMed titles | zorevunersen |
| Search PubMed titles/abstracts | zorevunersen |